Oral Semaglutide Uptake Hits 4.56 per 10,000 in 10 Weeks, Reshaping GLP-1 Market
A JAMA Network Open study finds oral semaglutide reached 4.56 weekly initiations per 10,000 eligible adults within 10 weeks of approval, with implications for peptide therapy clinics and GLP-1 supply chains.